Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study

By Gajria Kavita  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite

Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 587-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD

By Ambrosini Paul J.   Sallee Floyd R.   Lopez Frank A.   Shi Li   Michaels M. Alex    

Current Medical Research and Opinion, Vol. 22, Iss. 2, 2006-02 ,pp. : 427-440

Informa Healthcare

Access to resources Recommend Favorite

A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis

By Finn William F.   Joy Melanie S.    

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 657-664

Informa Healthcare

Access to resources Recommend Favorite

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability

By Montgomery Stuart   Emir Birol   Haswell Hannah   Prieto Rita  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1223-1230

Informa Healthcare

Access to resources Recommend Favorite